Larger number of invariant natural killer T cells in PBSC allografts correlates with improved GVHD-free and progression-free survival

Abstract : Key Points • Higher dose of invariant NKT cells within PBSC allograft is associated with an improved GPFS. We studied the impact of a set of immune cells contained within granulocyte colony-stimulating factor–mobilized peripheral blood stem cell grafts (na¨ıvena¨ıve and memory T-cell subsets, B cells, regulatory T cells, invariant natural killer T cells [iNKTs], NK cells, and dendritic cell subsets) in patients (n 5 80) undergoing allogeneic stem cell trans-plantation (SCT), using the composite end point of graft-versus-host disease (GVHD)-free and progression-free survival (GPFS) as the primary end point. We observed that GPFS incidences in patients receiving iNKT doses above and below the median were 49% vs 22%, respectively (P 5 .007). In multivariate analysis, the iNKT dose was the only parameter with a significant impact on GPFS (hazard ratio 5 0.48; 95% confidence interval, 0.27-0.85; P 5 .01). The incidences of severe grade III to IV acute GVHD and National Institutes of Health grade 2 to 3 chronic GVHD (12% and 16%, respectively) were low and associated with the use of antithymocyte globulin in 91% of patients. No difference in GVHD incidence was reported according to the iNKT dose. In conclusion, a higher dose of iNKTs within the graft is associated with an improved GPFS. These data may pave the way for prospective and active interventions aiming to manipulate the graft content to improve allo
Type de document :
Article dans une revue
Blood, American Society of Hematology, 2016, 127, pp.1828 - 1835. 〈10.1182/blood-2015-12-688739〉
Liste complète des métadonnées

Littérature citée [38 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-01408681
Contributeur : Elizabeth Bernardo <>
Soumis le : lundi 5 décembre 2016 - 11:28:01
Dernière modification le : jeudi 5 avril 2018 - 10:37:00
Document(s) archivé(s) le : mardi 21 mars 2017 - 14:36:59

Fichier

 Accès restreint
Fichier visible le : jamais

Connectez-vous pour demander l'accès au fichier

Identifiants

Collections

Citation

Florent Malard, Myriam Labopin, Patrice Chevallier, Thierry Guillaume, Alix Duquesne, et al.. Larger number of invariant natural killer T cells in PBSC allografts correlates with improved GVHD-free and progression-free survival. Blood, American Society of Hematology, 2016, 127, pp.1828 - 1835. 〈10.1182/blood-2015-12-688739〉. 〈inserm-01408681〉

Partager

Métriques

Consultations de la notice

104